Jan 8NuvOx Pharma Announces Issuance of a New PatentTucson, AZ, January 2, 2024 - NuvOx Pharma has been issued US Patent No. 11,857,627, entitled “Fractionated Radiotherapy and...
Nov 2, 2023NuvOx Announces Contract to Support NOVEL TrialTucson, AZ, USA, October 31, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic...
Oct 2, 2023NuvOx Therapeutics Wins Most Fundable Company by Pepperdine Graziadio Business SchoolTucson, AZ, September 28th, 2023 NuvOx Therapeutics (“NuvOx”) is delighted to announce that it achieved the Gold Level recognition on the...
Sep 25, 2023NuvOx Closed Oversubscribed Convertible NotesTucson, AZ, September 18th, 2023 NuvOx Therapeutics (“NuvOx”) announced that it has closed an oversubscribed convertible notes round,...